Arcutis Biotherapeutics Inc (ARQT)
SG&A Expenses
$297.60M
TTM · Period ending: · USD
ARQT SG&A Expenses
Latest reported$297.60Mperiod ending
Latest reported$297.60Mperiod ending
ARQT TTM SG&A Expenses ($1.80M → $297.60M)
TTM SG&A Expenses
High-resolution chart · PNG
ARQT sg&a expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | SG&A Expenses (USD) |
|---|---|
| 297,595,000 | |
| 284,627,000 | |
| 274,553,000 | |
| 253,183,000 | |
| 249,596,000 | |
| 238,599,000 | |
| 229,391,000 | |
| 220,458,000 | |
| 209,236,000 | |
| 197,021,000 | |
| 185,145,000 | |
| 173,494,000 | |
| 161,372,000 | |
| 143,036,000 | |
| 122,124,000 | |
| 103,829,000 | |
| 84,830,000 | |
| 68,523,000 | |
| 60,971,000 | |
| 48,933,000 | |
| 38,019,000 | |
| 32,322,000 | |
| 21,337,000 | |
| 16,884,000 | |
| 13,624,000 | |
| 9,330,000 | |
| 6,610,000 | |
| 4,979,000 | |
| 3,293,000 | |
| 2,256,500 | |
| 1,795,000 |